Less Ads, More Data, More Tools Register for FREE

Pin to quick picksInterContinental Hotels Regulatory News (IHG)

Share Price Information for InterContinental Hotels (IHG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 8,180.00
Bid: 8,174.00
Ask: 8,176.00
Change: -46.00 (-0.56%)
Spread: 2.00 (0.024%)
Open: 8,264.00
High: 8,314.00
Low: 8,126.00
Prev. Close: 8,226.00
IHG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on 2023 Annual General Meeting vote

1 Nov 2023 16:00

RNS Number : 0891S
InterContinental Hotels Group PLC
01 November 2023

1 November 2023

InterContinental Hotels Group PLC

Update on 2023 Annual General Meeting vote

At the InterContinental Hotels Groups PLC ("IHG") Annual General Meeting ("AGM") on 5 May 2023, resolution 2 (Directors' Remuneration Policy) received the support of 74.85% of shareholder votes, and resolution 3 (Directors' Remuneration Report 2022) received the support of 76.94% of shareholder votes.

The Directors' Remuneration Policy ("DRP") is on pages 10 to 26 of the 2023 Notice of Annual General Meeting: https://www.ihgplc.com/en/investors/shareholder-centre/agms-and-meetings. The Directors' Remuneration Report 2022 ("DRR") is on pages 114 to 136 of the Annual Report and Form 20-F 2022: https://www.ihgplc.com/en/investors/shareholder-centre/annual-reports-and-responsible-business-reports.

Prior to the DRP and DRR resolutions being put to shareholders at the 2023 AGM, the Remuneration Committee consulted extensively with shareholders and the major proxy agencies on the key features of the DRP and the decisions in relation to 2022 pay outcomes. The consultation included engaging with around 60% of the ownership of the Company. All of IHG's 10 largest shareholders on the register at that time voted in support of the DRP and DRR; of IHG's 25 largest holders at that time, there were only three who voted against the DRP and two against the DRR.

Following the AGM, the Board acknowledged that some shareholders had concerns with the DRP and DRR and committed to engaging with shareholders in relation to this. Since then, the current Chair of the Remuneration Committee, along with the incoming Remuneration Committee Chair (effective from 1 January 2024), have held follow-up conversations with seven major shareholders, as well as Institutional Shareholder Services ("ISS") and the Investment Association. This included shareholders that voted both for and against the DRP and DRR.

In those discussions, shareholder views in relation to the following matters, amongst others, were heard:

· the DRP provision for the increase in maximum LTIP awards (by 150% of salary to 500% for CEO and US-based Executive Directors, and by 25% of salary to 300% for other Executive Directors); and

· the use of positive discretion in relation to the Cash Flow measure in the 2020/22 Long Term Incentive Plan award on the basis of the reasoning set out in the DRR.

The Board recognises that a range of views exists across the shareholder base in relation to the pay of Executive Directors. The Board notes the 74.85% voting support level received on the DRP and 76.94% level on the DRR and continues to believe that the commercial rationale for the DRP changes is critical to the retention and development of global talent in order to drive the long-term success of the business.

The views expressed by shareholders, ISS and the Investment Association in the most recent round of consultations following the AGM will be taken into consideration as the Remuneration Committee continues to keep the DRP under ongoing review, and as it determines payments and awards to be made under the terms of the DRP.

The Board and the Remuneration Committee would like to thank shareholders and proxy agencies for their engagement and input in relation to this DRP and will continue to engage with shareholders in relation to Executive Director pay going forward.

ENDS

For further information, please contact:

Investor Relations

Stuart Ford (+44 (0)7823 828 739); Aleksandar Milenkovic (+44 (0)7469 905 720)

Joe Simpson (+44 (0)7976 862 072)

Media Relations

Neil Maidment (+44 (0)7970 668 250)

Mike Ward (+44 (0)7795 257 407)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
AGMUAAVROBUARAA
Date   Source Headline
30th May 20172:00 pmRNSDirector/PDMR Shareholding
30th May 20171:55 pmRNSHolding(s) in Company
24th May 20172:01 pmRNSDirector/PDMR Shareholding
24th May 20172:00 pmRNSDirector/PDMR Shareholding
11th May 201712:04 pmRNSSterling Equivalents - Final & Special Dividends
5th May 20171:32 pmRNSResult of AGM
5th May 20177:01 amRNSDirectorate Change
5th May 20177:00 amRNSFirst Quarter Trading Update 2017
2nd May 20172:00 pmRNSTotal Voting Rights
21st Apr 20173:30 pmRNSTransaction in Own Shares
20th Apr 20174:00 pmRNSRepurchase, Special Div and Share Consolidation
4th Apr 20172:05 pmRNSDirector/PDMR Shareholding
4th Apr 20172:00 pmRNSDirector/PDMR Shareholding
4th Apr 201711:00 amRNSNotice of AGM, Special Div and Share Consolidation
3rd Apr 20172:00 pmRNSTotal Voting Rights
17th Mar 20172:00 pmRNSDirector/PDMR Shareholding
13th Mar 201711:00 amRNSDirector/PDMR Shareholding
6th Mar 201711:01 amRNSDirector/PDMR Shareholding
6th Mar 201711:00 amRNSDirector/PDMR Shareholding
2nd Mar 20171:51 pmRNSAnnual Financial Report
1st Mar 20172:00 pmRNSTotal Voting Rights
1st Mar 201711:01 amRNSDirector/PDMR Shareholding
1st Mar 201711:00 amRNSDirector/PDMR Shareholding
27th Feb 201710:01 amRNSDirector/PDMR Shareholding
27th Feb 201710:00 amRNSDirector/PDMR Shareholding
21st Feb 20177:01 amRNSDirectorate Change
21st Feb 20177:00 amRNSFinal Results
1st Feb 20172:00 pmRNSTotal Voting Rights
5th Jan 201711:00 amRNSDirector/PDMR Shareholding
3rd Jan 20172:00 pmRNSTotal Voting Rights
22nd Dec 201610:00 amRNSHolding(s) in Company
16th Dec 201610:05 amRNSHolding(s) in Company
2nd Dec 201611:00 amRNSDirector/PDMR Shareholding
1st Dec 20162:00 pmRNSTotal Voting Rights
18th Nov 201610:00 amRNSHolding(s) in Company
17th Nov 201610:00 amRNSHolding(s) in Company
11th Nov 20163:30 pmRNSHolding(s) in Company
9th Nov 201611:01 amRNSHolding(s) in Company
1st Nov 20162:00 pmRNSTotal Voting Rights
1st Nov 201611:00 amRNSDirector/PDMR Shareholding
27th Oct 201611:36 amRNSDirector/PDMR Shareholding
21st Oct 20167:00 amRNSThird Quarter Trading Update
6th Oct 201610:00 amRNSHolding(s) in Company
3rd Oct 201612:00 pmRNSTotal Voting Rights
30th Sep 201610:10 amRNSHolding(s) in Company
29th Sep 20164:20 pmRNSIHG Investor and Analyst Event
26th Sep 201610:00 amRNSDirector Declaration
21st Sep 20164:00 pmRNSHolding(s) in Company
19th Sep 201612:48 pmRNSPost Stabilisation Notice
8th Sep 20163:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.